Judge Blocks Key Evidence, Tylenol Pregnancy Lawsuit Collapses as Kenvue Shares Riseπ₯87
9/25/2025β’Health > Pharmaceuticals
- β’The case alleged acetaminophen use during pregnancy could cause autism and developmental disorders.
- β’The ruling ended the lawsuit targeting Kenvue Inc., maker of Tylenol.
- β’Kenvueβs stock rose 1.64%, closing at \$21.36 after the decision.
- β’The judge ruled scientific evidence presented did not meet admissibility standards.
- β’Tylenol has long been recommended as safe for pregnancy compared to alternatives.
